Trial of Patterned Oral Somatosensory Entrainment for Shortening Time to Oral Feeding

NCT ID: NCT01158391

Last Updated: 2016-05-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

210 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-05-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary hypothesis is that the preterm infants (26 0/7 to 30 6/7 weeks gestational age) who undergo the NTrainer System® training will transition to full oral feeds faster than the control group (i.e. the study group will be superior to the control).

The secondary hypothesis is that the infants in the NTrainer System® experimental group will have shorter lengths of stay.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patterned Oral Somatosensory Intervention

The interventions (Treatment vs Control) will be initiated simultaneously with tube (gavage) feeds as early as 30 weeks post-menstrual age. Before and during each training session the infant will be evaluated for the following criteria:

Criteria for Initiation of each intervention:

1. Not on continuous vasopressor medications
2. Feeding in previous 48 hours.
3. Not mechanically ventilated. If the infant is on CPAP or Nasal cannula \>2 liters per minute, then the FiO2 must be \<40%.

Criteria for Exiting an Intervention Session:

1. If during an intervention the baby experiences Apnea/Bradycardic/Desaturation events requiring nursing stimulation or intervention during the training--hold future interventions for one session.
2. If the interventions are held for 3 consecutive sessions, hold interventions for a full day (24 hours).
3. If interventions are held for 3 days (72 hours) and if GA is \<32 weeks when ready to restart therapy sessions, then complete another 10 days of interventions.
4. If interventions are held for 3 days (72 hours) and if GA is \>32 weeks when ready to restart therapy, then complete the remaining N interventions sessions for a total of 10 days of therapy.
5. If interventions are held for 3 days (72 hours) and the infant is on full oral feeds when ready to restart therapy interventions then discontinue any remaining interventions sessions.

The Interventions

Infants in the Treatment and Control group will receive orocutaneous stimulation up to four times daily during the first 30 minutes of a tube (gavage) feeding session to achieve an average of 30 therapy sessions distributed over a two week period.

Infants assigned to the either group will be offered the pacifier by gently placing the pacifier on the lips. The pacifier should not be forced into the mouth and should not be moved in any manner that would represent any form of patterned input such as moving the pacifier in and out, tapping on the lips or face or massaging the mouth or oral facial structure.

All other preparatory, infant positioning, and sampling conditions will be equal among groups. The healthcare team will continue to promote feeding and growth at the standard of care for babies in both groups.

Treatment Group

Infants in the Treatment group will receive the NTrainer System® patterned synthetic orocutaneous stimulation. A single NTrainer intervention runs for 20 minutes and involves three 3 minute sessions during which the pacifier pulses. The pulsing sessions are separated by 5.5 min breaks where the pacifier is quiet.

Control Group

Infants assigned to the control group will receive an orocutaneous intervention in which the infant will be offered a 20 minute non-nutritive sucking opportunity with a 'quiet' pacifier.

Breast Feeding Non-nutritive breastfeeding and nutritive breastfeeding practice will not be altered or changed by the interventions. The availability of the mother will be taken into consideration for the scheduling of any intervention sessions and no study intervention will interfere with breastfeeding behavior.

Safety To help ensure the safety of the study participants the heart rate, oxygen saturation, and blood pressure will be monitored throughout the therapy session.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infant, Extremely Premature Length of Stay Feeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NTrainer® Intervention

NTrainer® Intervention - Infants in the experimental group will receive the NTrainer System patterned synthetic orocutaneous stimulation during the first 30 minutes of a tube (gavage) feeding session. The intervention may be provided up to 4 times daily to achieve an average of 30 sessions distributed over a two week period.

Group Type EXPERIMENTAL

NTrainer® Intervention

Intervention Type DEVICE

Control Intervention

Control Intervention - Infants in the Control group will be provided orocutaneous stimulation with a 'quiet pacifier' during the first 30 minutes of a tube (gavage) feeding session. The intervention may be provided up to 4 times daily to achieve an average of 30 sessions distributed over a two week period.

Group Type SHAM_COMPARATOR

Control Intervention

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NTrainer® Intervention

Intervention Type DEVICE

Control Intervention

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

KC BioMedix NTrainer NTrainer System Actifier Non-nutritive Sucking NNS Opportunity

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Birth Gestational age 26 0/6 - 30 6/7 weeks

Exclusion Criteria

* Chromosomal abnormalities
* Congenital anomalies included but not limited to
* craniofacial malformation
* cyanotic congenital heart disease
* gastroschisis
* omphalocele
* diaphragmatic hernia or other major gastrointestinal anomalies
* Major neurological anomaly
* Infants with history of surgical necrotizing enterocolitis (stage III)
* Infants with vocal cord paralysis
* Infants with neonatal seizures
* Infants with meningitis at time of enrollment
* Infants who are nippling all feeds at the time of enrollment
* Infants with narcotic abstinence syndrome (NAS)
* Infants enrolled in another clinical study
Minimum Eligible Age

26 Weeks

Maximum Eligible Age

31 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Innara Health, Inc.

INDUSTRY

Sponsor Role collaborator

KC BioMediX, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dongli Song, MD

Role: PRINCIPAL_INVESTIGATOR

Santa Clara Valley Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Santa Clara Valleye Medical Center

San Jose, California, United States

Site Status

Montefiore Medical Center Weiler Hopsital

The Bronx, New York, United States

Site Status

Montefiore Medical Center - Wakefield Hopsital

The Bronx, New York, United States

Site Status

Cook Children's Medical Center

Fort Worth, Texas, United States

Site Status

North Central Baptist Hospital

San Antonio, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Song D, Jegatheesan P, Nafday S, Ahmad KA, Nedrelow J, Wearden M, Nemerofsky S, Pooley S, Thompson D, Vail D, Cornejo T, Cohen Z, Govindaswami B. Patterned frequency-modulated oral stimulation in preterm infants: A multicenter randomized controlled trial. PLoS One. 2019 Feb 28;14(2):e0212675. doi: 10.1371/journal.pone.0212675. eCollection 2019.

Reference Type DERIVED
PMID: 30817764 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KC_BMDX_002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Massage Therapy in Premature Neonates
NCT06163586 ACTIVE_NOT_RECRUITING NA
BabySTrong II taVNS Feeding Trial
NCT07049952 RECRUITING PHASE2/PHASE3